Over the past decade, studies have shown GLP-1 receptor agonists like semaglutide (Ozempic or Wegovy) reduce food seeking, but also alcohol intake, cocaine reward, nicotine self-administration, and relapse-like behavior spanning multiple drug classes
A.BurcallL.MpandeC.JenkinsN.et al (2010)
Among these, injectable treatments stand out for their effectiveness, convenience, and minimally invasive nature
Switching to a Different GLP-1 Agonist: If nausea and vomiting persist despite dose adjustments and supportive therapies, your healthcare provider may consider switching to a different GLP-1 agonist
The psychedelic renaissance has sparked new hope for the treatment of many behavioral and neuropsychiatric conditions that havesimilarly to the management of obesityshown to be extremely treatment-resistant [7]
Our product is cruelty free and is manufactured according to sustainable and environmentally friendly methods